Section: Wildlife Bacteria

Mycobacterium bovis in Wildlife: Reservoir Hosts and Diagnostic Challenges

Introduction

Mycobacterium bovis is the primary causative agent of bovine tuberculosis (bTB), a chronic granulomatous disease that affects a broad range of mammalian hosts. While domestic cattle have historically been the focus of bTB control programs, the recognition of wildlife reservoirs has fundamentally altered the epidemiological landscape of this pathogen. Wildlife species can maintain M. bovis infection independently of livestock, serve as spillover hosts, or act as bridge vectors that facilitate transmission across the livestock-wildlife interface [1, 2]. The persistence of M. bovis in wildlife populations complicates eradication efforts in domestic livestock and necessitates a One Health approach to disease management.

This article provides an exhaustive review of M. bovis in wildlife, focusing on reservoir host species, transmission dynamics at the livestock-wildlife interface, diagnostic modalities including interferon-gamma (IFN-gamma) release assays and polymerase chain reaction (PCR), and management strategies. The discussion is confined to veterinary and wildlife contexts, with emphasis on the biophysical and molecular mechanisms underlying host-pathogen interactions and diagnostic test performance.

Microbiology and Pathogenesis of Mycobacterium bovis

M. bovis is a member of the Mycobacterium tuberculosis complex (MTBC), a group of genetically related obligate intracellular pathogens. The organism is an acid-fast, non-motile, slow-growing bacillus with a lipid-rich cell wall composed of mycolic acids, arabinogalactan, and peptidoglycan [3]. The mycolic acid layer confers resistance to desiccation, disinfectants, and environmental stressors, enabling prolonged survival in soil, water, and organic matter for weeks to months under favorable conditions [4].

The primary route of infection in wildlife is via the respiratory tract through inhalation of aerosolized bacilli. Alveolar macrophages phagocytose M. bovis, but the bacterium evades intracellular killing by inhibiting phagosome-lysosome fusion and resisting reactive oxygen and nitrogen intermediates [5]. The pathogen replicates within macrophages, triggering a cell-mediated immune response characterized by the formation of granulomas. These granulomas consist of a central core of epithelioid macrophages and multinucleated giant cells surrounded by lymphocytes and fibrous connective tissue [6]. In immunocompetent hosts, granulomas may contain the infection, but in many wildlife species, lesions progress to caseous necrosis and cavitation, facilitating bacterial shedding into airways and the environment [7].

Wildlife Reservoir Hosts

A reservoir host is defined as a species in which M. bovis can be maintained indefinitely and from which transmission to other species occurs. The identification of reservoir hosts is critical for targeted surveillance and control. The following table summarizes the major wildlife reservoir hosts by geographic region.

Geographic Region Primary Reservoir Host Secondary/Spillover Hosts Key Transmission Features
British Isles Eurasian badger (Meles meles) Red deer, fallow deer, wild boar Direct contact at badger setts; pasture contamination with urine and sputum
New Zealand Brushtail possum (Trichosurus vulpecula) Red deer, feral pigs, ferrets Respiratory transmission; possums exhibit high shedding intensity
Iberian Peninsula Eurasian wild boar (Sus scrofa) Red deer, fallow deer, cattle High-density populations; aggregation at feeding sites
North America White-tailed deer (Odocoileus virginianus) Elk, bison, coyotes, raccoons Concentrated feeding and baiting practices amplify transmission
South Africa African buffalo (Syncerus caffer) Kudu, warthog, lion Maintenance in buffalo herds; spillover to predators via infected prey
Australia Feral water buffalo (Bubalus bubalis) Feral pigs, brushtail possum Limited geographic foci; eradication programs in progress

Eurasian Badger (Meles meles)

The Eurasian badger is the most extensively studied wildlife reservoir of M. bovis, particularly in the United Kingdom and Ireland. Badgers develop generalized tuberculosis with lesions in the lungs, kidneys, and lymph nodes [8]. Infected badgers shed M. bovis in sputum, urine, and feces, contaminating pasture and latrine sites. Transmission to cattle occurs through direct contact at badger setts or indirect exposure via contaminated forage [9]. Longitudinal studies using molecular typing have demonstrated that M. bovis strains circulating in badger populations are genetically identical to those isolated from cattle in the same geographic area, confirming bidirectional transmission [10].

Brushtail Possum (Trichosurus vulpecula)

In New Zealand, the brushtail possum serves as the primary wildlife reservoir. Possums develop severe pulmonary tuberculosis with extensive cavitation, leading to high bacterial shedding in respiratory secretions [11]. The nocturnal behavior and high population density of possums facilitate transmission to cattle through pasture contamination. Control programs combining population reduction and vaccination have achieved significant reductions in bTB prevalence in both possums and cattle [12].

Eurasian Wild Boar (Sus scrofa)

In the Iberian Peninsula, wild boar are considered a maintenance host for M. bovis. Infection prevalence in wild boar populations can exceed 50% in areas with high density and supplemental feeding [13]. Wild boar exhibit a wide range of pathological presentations, from subclinical latent infection to disseminated disease with pulmonary and lymph node lesions. The species is highly gregarious, and transmission occurs through direct contact, aerosol inhalation, and ingestion of contaminated feed or water [14].

White-Tailed Deer (Odocoileus virginianus)

In Michigan, USA, white-tailed deer are the primary wildlife reservoir. Infection is concentrated in the northeastern Lower Peninsula, where deer densities are high and supplemental feeding is common [15]. Deer-to-deer transmission occurs through direct contact and aerosolization at feeding sites. Spillover to cattle has been documented, and management strategies have focused on banning supplemental feeding and reducing deer density [16].

African Buffalo (Syncerus caffer)

In southern Africa, African buffalo are the principal maintenance host in protected areas. Infection prevalence in buffalo herds can reach 30% to 40% [17]. Buffalo-to-buffalo transmission occurs via the respiratory route, and spillover to other wildlife species including kudu, warthog, and lion has been documented. Predators become infected through consumption of infected prey, but they are generally considered dead-end hosts [18].

Transmission at the Livestock-Wildlife Interface

The livestock-wildlife interface is a dynamic zone where ecological, behavioral, and anthropogenic factors converge to facilitate M. bovis transmission. Key factors include:

  1. Shared grazing areas: Cattle and wildlife often share pasture, particularly in extensive farming systems. Contamination of pasture with infected urine, feces, or sputum leads to indirect transmission [19].

  2. Supplemental feeding and baiting: In North America and Europe, supplemental feeding of wildlife for hunting or conservation purposes concentrates animals at feeding sites, increasing contact rates and pathogen transmission [20].

  3. Water sources: Shared water troughs and natural water bodies can become contaminated with M. bovis, particularly in arid regions where water is a limiting resource [21].

  4. Fence-line contact: In areas where cattle and wildlife are separated by fences, direct contact through fence lines can result in transmission, particularly for badgers and wild boar [22].

  5. Livestock movement: The movement of infected cattle into areas with susceptible wildlife populations can introduce M. bovis into naive wildlife communities [23].

The following Mermaid diagram illustrates the transmission pathways at the livestock-wildlife interface.

flowchart TD
    A[Infected Wildlife Reservoir], > B[Direct Contact with Cattle]
    A, > C[Contamination of Pasture/Water]
    A, > D[Contamination of Feed/Supplements]
    B, > E[Cattle Infection]
    C, > E
    D, > E
    E, > F[Shedding by Infected Cattle]
    F, > G[Contamination of Environment]
    G, > A
    G, > H[Infection of Naive Wildlife]
    H, > A
    E, > I[Within-Herd Transmission]
    I, > E
    A, > J[Transmission to Other Wildlife Species]
    J, > A

Diagnostic Challenges in Wildlife

Diagnosing M. bovis infection in wildlife presents unique challenges compared to domestic livestock. These challenges include the lack of validated tests for many species, the difficulty of sample collection from free-ranging animals, and the variable immune responses across different taxa.

Ante-Mortem Diagnostic Tests

Intradermal Tuberculin Test

The single intradermal comparative cervical tuberculin test (SICCT) is the standard diagnostic test for bTB in cattle. In wildlife, the test has been adapted for use in badgers, deer, and wild boar, but its sensitivity and specificity vary considerably across species [24]. In badgers, the test sensitivity ranges from 40% to 70%, and specificity is compromised by cross-reactivity with environmental mycobacteria [25]. The test requires handling and restraint of animals, which is logistically challenging for free-ranging populations.

Interferon-Gamma Release Assay (IGRA)

The IFN-gamma release assay measures cell-mediated immune responses by quantifying IFN-gamma production by sensitized T lymphocytes following stimulation with M. bovis-specific antigens, including early secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) [26]. These antigens are encoded by the region of difference 1 (RD1) gene cluster, which is present in M. bovis but absent from most environmental mycobacteria and the vaccine strain M. bovis BCG [27].

The IGRA has been validated for use in badgers, deer, wild boar, and African buffalo [28, 29, 30]. In badgers, the test sensitivity is approximately 80% with specificity exceeding 90% [31]. The assay requires whole blood samples that must be processed within 8 to 12 hours of collection, which is a significant limitation for field studies in remote areas. The use of heparinized blood tubes and portable incubators can mitigate this constraint.

The biophysical basis of the IGRA involves the binding of M. bovis antigens to major histocompatibility complex (MHC) class II molecules on antigen-presenting cells, which then activate memory T helper 1 (Th1) cells. Activated Th1 cells secrete IFN-gamma, which is detected using an enzyme-linked immunosorbent assay (ELISA) [32]. The sensitivity of the assay depends on the antigen cocktail used, the incubation time, and the cutoff threshold for positivity.

Enzyme-Linked Immunosorbent Assay (ELISA)

Serological assays detect antibodies against M. bovis antigens. While cell-mediated immunity is the dominant response in early infection, antibody levels increase as disease progresses, particularly in animals with disseminated lesions [33]. The multi-antigen print immunoassay (MAPIA) and the chemiluminescent ELISA have been used in badgers, deer, and wild boar [34, 35]. The sensitivity of serological tests is lower than that of IGRA in early infection, but they are useful for detecting advanced disease and for screening large numbers of animals.

The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a methodological parallel for understanding antigen capture and detection principles, although the target antigens and host species differ.

Post-Mortem Diagnostic Tests

Gross Pathology and Histopathology

Post-mortem examination remains a cornerstone of wildlife surveillance. Typical lesions include caseous granulomas in the lungs, tracheobronchial and mediastinal lymph nodes, and occasionally in the liver, spleen, and kidneys [36]. In badgers, lesions are frequently found in the kidneys, which correlates with urinary shedding [37]. Histopathological examination reveals acid-fast bacilli on Ziehl-Neelsen staining, but the sensitivity of microscopy is low, particularly in animals with paucibacillary lesions [38].

Mycobacterial Culture

Culture is the gold standard for M. bovis diagnosis. Samples are decontaminated using N-acetyl-L-cysteine-sodium hydroxide (NALC-NaOH) or oxalic acid, then inoculated onto solid media such as Lowenstein-Jensen or Middlebrook 7H11 agar, or into liquid media such as BACTEC MGIT 960 [39]. The slow growth rate of M. bovis (3 to 8 weeks for primary isolation) delays diagnosis. Culture sensitivity is affected by sample quality, decontamination procedures, and the bacterial load in the tissue [40].

Polymerase Chain Reaction (PCR)

PCR-based methods offer rapid detection of M. bovis DNA in tissue samples. Targets include the insertion sequence IS6110, which is present in multiple copies in the M. tuberculosis complex, and the RD1 region [41]. Real-time PCR (qPCR) provides quantitative data and can detect as few as 10 to 100 colony-forming units per gram of tissue [42]. Multiplex PCR assays that differentiate M. bovis from other MTBC members have been developed using targets such as oxyR, pncA, and gyrB [43].

The sensitivity of PCR is higher than culture for samples with low bacterial loads, but false negatives can occur due to PCR inhibitors in tissue samples, particularly those with high lipid content [44]. DNA extraction protocols using cetyltrimethylammonium bromide (CTAB) or silica membrane columns are effective at removing inhibitors [45].

The diagnostic workflow for M. bovis in wildlife is summarized in the following table.

Test Modality Sample Type Sensitivity Specificity Turnaround Time Limitations
Intradermal test Live animal 40-70% 80-95% 72 hours Requires handling; cross-reactivity
IGRA Whole blood 75-90% 85-95% 24-48 hours Sample stability; requires laboratory
ELISA Serum 50-80% 85-95% 4-6 hours Lower sensitivity in early infection
Culture Tissue/swab 80-95% 100% 3-8 weeks Slow; requires viable bacteria
qPCR Tissue/swab 85-95% 95-100% 4-8 hours Inhibitors; cannot distinguish viable from dead bacteria

Molecular Epidemiology and Genotyping

Molecular typing methods are essential for understanding transmission dynamics and identifying sources of infection. Spoligotyping targets the direct repeat (DR) region of the M. bovis genome, which contains multiple direct repeats interspersed with unique spacer sequences [46]. Mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing analyzes 12 to 24 loci and provides higher discriminatory power than spoligotyping [47]. Whole genome sequencing (WGS) offers the highest resolution and can identify transmission clusters and directionality of spread [48].

WGS analysis of M. bovis isolates from wildlife and cattle has demonstrated that transmission is frequently bidirectional, with wildlife acting as both sources and sinks of infection [49]. The application of WGS in wildlife surveillance is limited by the cost and the requirement for high-quality DNA from cultured isolates.

Management Strategies

Management of M. bovis in wildlife requires an integrated approach combining population management, vaccination, biosecurity, and surveillance.

Population Management

Culling of wildlife reservoirs has been implemented in several countries. In the UK, badger culling has been controversial, with studies showing variable efficacy depending on the intensity and spatial scale of culling [50]. In New Zealand, possum population reduction through trapping and poisoning has been highly effective in reducing bTB prevalence [12]. In Michigan, deer population reduction through increased hunting and bans on supplemental feeding has reduced infection prevalence [16].

Vaccination

Oral vaccination of wildlife is a promising strategy. M. bovis BCG vaccine has been shown to reduce the severity of disease and bacterial shedding in badgers, possums, and wild boar [51, 52]. The vaccine is administered in bait formulations, which are distributed in the field. The efficacy of BCG vaccination varies, and it does not prevent infection entirely, but it reduces transmission rates [53].

Biosecurity

Biosecurity measures at the livestock-wildlife interface include fencing to exclude wildlife from cattle facilities, securing feed stores, and avoiding the use of shared water sources [54]. In areas with high wildlife density, double fencing with an electric wire can reduce contact between cattle and badgers or wild boar [55].

Surveillance

Active surveillance programs using a combination of post-mortem examination, culture, and PCR are essential for monitoring infection prevalence in wildlife populations. Passive surveillance of found-dead animals and hunter-harvested animals provides valuable data at low cost [56]. The integration of surveillance data with molecular epidemiology enables targeted interventions.

Conclusion

Mycobacterium bovis infection in wildlife represents a persistent challenge to bTB eradication programs worldwide. The diversity of reservoir hosts, the complexity of transmission at the livestock-wildlife interface, and the limitations of current diagnostic tests necessitate a multidisciplinary approach. Advances in molecular diagnostics, including IGRA and PCR, have improved the detection of infection in wildlife, but logistical constraints remain. Integrated management strategies combining population control, vaccination, and biosecurity offer the best prospects for reducing the impact of M. bovis in wildlife and protecting livestock health.

References

[1] Corner LAL. The role of wild animal populations in the epidemiology of tuberculosis in domestic animals: how to assess the risk. Vet Microbiol. 2006;112(2-4):303-312.

[2] Palmer MV, Waters WR, Whipple DL. Shared feed as a means of deer-to-deer transmission of Mycobacterium bovis. J Wildl Dis. 2004;40(1):87-91.

[3] Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29-63.

[4] Fine AE, Bolin CA, Gardiner JC, Kaneene JB. A study of the persistence of Mycobacterium bovis in the environment under natural weather conditions in Michigan, USA. Vet Med Int. 2011;2011:765430.

[5] Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol. 2001;2(8):569-577.

[6] Cassidy JP, Bryson DG, Pollock JM, Evans RT, Forster F, Neill SD. Early lesion formation in cattle experimentally infected with Mycobacterium bovis. J Comp Pathol. 1998;119(1):27-44.

[7] Gavier-Widen D, Chambers MA, Palmer N, Newell DG, Hewinson RG. Pathology of natural Mycobacterium bovis infection in European badgers (Meles meles) and its relationship with bacterial excretion. Vet Rec. 2001;148(10):299-304.

[8] Gallagher J, Clifton-Hadley RS. Tuberculosis in badgers: a review of the disease and its significance for other animals. Res Vet Sci. 2000;69(3):203-217.

[9] Woodroffe R, Donnelly CA, Jenkins HE, et al. Culling and cattle controls influence tuberculosis risk for badgers. Proc Natl Acad Sci USA. 2006;103(40):14713-14717.

[10] Biek R, O'Hare A, Wright D, et al. Whole genome sequencing reveals local transmission patterns of Mycobacterium bovis in sympatric cattle and badger populations. PLoS Pathog. 2012;8(11):e1003008.

[11] Cooke MM, Alley MR, Murray A. The pathology of Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula). N Z Vet J. 1995;43(7):285-291.

[12] Livingstone PG, Hancox N, Nugent G, de Lisle GW. Toward eradication of bovine tuberculosis in New Zealand: a history, review, and recommendations. N Z Vet J. 2015;63(Suppl 1):4-16.

[13] Vicente J, Hofle U, Garrido JM, et al. Wild boar and red deer display high prevalences of tuberculosis-like lesions in Spain. Vet Rec. 2006;159(1):22-23.

[14] Naranjo V, Gortazar C, Vicente J, de la Fuente J. Evidence of the role of European wild boar as a reservoir of Mycobacterium tuberculosis complex. Vet Microbiol. 2008;127(1-2):1-9.

[15] O'Brien DJ, Schmitt SM, Fitzgerald SD, Berry DE, Hickling GJ. Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience. Vet Microbiol. 2006;112(2-4):313-323.

[16] O'Brien DJ, Schmitt SM, Rudolph BA, Nugent G. Recent advances in the management of bovine tuberculosis in free-ranging wildlife. Vet Microbiol. 2011;151(1-2):23-30.

[17] De Vos V, Bengis RG, Kriek NP, et al. The epidemiology of tuberculosis in free-ranging African buffalo (Syncerus caffer) in the Kruger National Park, South Africa. Onderstepoort J Vet Res. 2001;68(2):119-130.

[18] Michel AL, Bengis RG, Keet DF, et al. Wildlife tuberculosis in South African conservation areas: implications and challenges. Vet Microbiol. 2006;112(2-4):91-100.

[19] Phillips CJC, Foster CRW, Morris PA, Teverson R. The transmission of Mycobacterium bovis from badgers to cattle. Res Vet Sci. 2003;74(1):1-15.

[20] Miller RS, Sweeney SJ, Slootmaker C, et al. Cross-species transmission of Mycobacterium bovis at the livestock-wildlife interface. Front Vet Sci. 2020;7:525.

[21] Barasona JA, Vicente J, Diez-Delgado I, Aznar J, Gortazar C, Torres MJ. Environmental presence of Mycobacterium tuberculosis complex in aggregation points at the wildlife/livestock interface. Transbound Emerg Dis. 2017;64(4):1148-1158.

[22] Ward AI, Judge J, Delahay RJ. Farm husbandry and badger behaviour: opportunities to manage badger to cattle transmission of Mycobacterium bovis. Prev Vet Med. 2010;93(1):2-10.

[23] Carstensen M, O'Brien DJ, Schmitt SM. Public acceptance as a determinant of management strategies for bovine tuberculosis in free-ranging U.S. wildlife. Vet Microbiol. 2011;151(1-2):200-204.

[24] Chambers MA, Crawshaw T, Waterhouse S, et al. Validation of the BrockTB Stat-Pak assay for detection of tuberculosis in Eurasian badgers (Meles meles) and influence of disease severity on diagnostic accuracy. J Clin Microbiol. 2008;46(4):1498-1500.

[25] de Lisle GW, Bengis RG, Schmitt SM, O'Brien DJ. Tuberculosis in free-ranging wildlife: detection, diagnosis and management. Rev Sci Tech. 2002;21(2):317-334.

[26] Wood PR, Jones SL. BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis. 2001;81(1-2):147-155.

[27] Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356(9235):1099-1104.

[28] Dalley D, Dave D, Lesellier S, et al. Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles). Tuberculosis. 2008;88(3):235-243.

[29] Waters WR, Palmer MV, Thacker TC, et al. Early antibody responses to experimental Mycobacterium bovis infection of cattle. Clin Vaccine Immunol. 2006;13(6):648-654.

[30] Michel AL, Cooper D, Jooste J, de Klerk LM, Jolles A. Approaches towards optimising the gamma interferon assay for diagnosing Mycobacterium bovis infection in African buffalo (Syncerus caffer). Prev Vet Med. 2011;98(2-3):142-148.

[31] Chambers MA, Lyashchenko KP, Greenwald R, et al. Evaluation of a rapid serological test for the determination of Mycobacterium bovis infection in badgers (Meles meles) found dead. Clin Vaccine Immunol. 2010;17(3):408-411.

[32] Buddle BM, Keen D, Thomson A, et al. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci. 1995;59(1):10-16.

[33] Lyashchenko KP, Greenwald R, Esfandiari J, et al. Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species. J Clin Microbiol. 2008;46(8):2725-2730.

[34] Lyashchenko KP, Singh M, Colangeli R, Gennaro ML. A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases. J Immunol Methods. 2000;242(1-2):91-100.

[35] Greenwald R, Esfandiari J, Lesellier S, et al. Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats. Diagn Microbiol Infect Dis. 2009;65(4):389-395.

[36] Gavier-Widen D, Chambers MA, Gortazar C, et al. Pathology of bovine tuberculosis in wildlife. Vet Pathol. 2009;46(5):803-814.

[37] Corner LAL, Murphy D, Gormley E. Mycobacterium bovis infection in the Eurasian badger (Meles meles): the disease, pathogenesis, epidemiology and control. J Comp Pathol. 2011;144(1):1-24.

[38] Hines N, Payeur JB, Hoffman LJ. Comparison of the recovery of Mycobacterium bovis isolates using the BACTEC MGIT 960 system and Lowenstein-Jensen medium. J Vet Diagn Invest. 2006;18(3):295-298.

[39] Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. US Department of Health and Human Services; 1985.

[40] Corner LAL, Gormley E, Pfeiffer DU. Primary isolation of Mycobacterium bovis from badgers: comparison of liquid and solid media. Vet Rec. 2012;170(4):102.

[41] Kox LFF, Rhienthong D, Miranda AM, et al. A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol. 1994;32(3):672-678.

[42] Taylor MJ, Hughes MS, Skuce RA, Neill SD. Detection of Mycobacterium bovis in bovine clinical specimens using real-time fluorescence and fluorescence resonance energy transfer probe rapid-cycle PCR. J Clin Microbiol. 2001;39(4):1272-1278.

[43] Huard RC, Lazzarini LC, Butler WR, van Soolingen D, Ho JL. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol. 2003;41(4):1637-1650.

[44] Radomski N, Kremer K, de Jong BC, et al. Evaluation of DNA extraction methods for molecular typing of Mycobacterium bovis. J Microbiol Methods